Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Sep 8:11:625.
doi: 10.3389/fendo.2020.00625. eCollection 2020.

Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study

Affiliations
Observational Study

Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study

Georgios S Panagoulias et al. Front Endocrinol (Lausanne). .

Abstract

Research Question: Previous cross-sectional studies have shown an association between sudomotor dysfunction and diabetic foot ulceration (DFU). The aim of this prospective multicenter study was to determine the role of dryness of foot skin and of established neurological modalities in the prediction of risk for foot ulceration in a cohort of individuals with diabetes mellitus (DM). Design: The study was conducted from 2012 to 2017. A total of 308 subjects with DM without history of DFU or critical limb ischemia completed the study. Diabetic neuropathy was assessed using the neuropathy symptom score (NSS) and neuropathy disability score (NDS). In a subset of participants, vibration perception threshold (VPT) was evaluated. Dryness of foot skin was assessed by the visual indicator plaster method (IPM). The diagnostic performance of the above neurological modalities for prediction of DFU was tested by receiver operating characteristic curve (ROC) analysis. Results: During the 6-year follow-up, 55 patients (annual ulceration incidence 2.97%) developed DFU. Multivariate Cox-regression analysis after controlling for the effect of age, gender, and DM duration demonstrated that the risk (hazard ratio, 95% confidence intervals) of DFU increased significantly with either abnormal IPM (3.319, 1.460-7.545, p = 0.004) or high (≥6) NDS (2.782, 1.546-5.007, p = 0.001) or high (≥25 volts) VPT (2.587, 1.277-5.242, p = 0.008). ROC analysis showed that all neurological modalities could discriminate participants who developed DFU (p < 0.001). IPM testing showed high sensitivity (0.86) and low specificity (0.49), while high vs. low NDS and VPT showed low sensitivity (0.40 and 0.39, respectively) and high specificity (0.87 and 0.89, respectively) for identification of patients at risk for DFU. Conclusion: Dryness of foot skin assessed by the IPM predicts the development of DFU. IPM testing has high sensitivity, whereas high NDS and VPT have high specificity in identifying subjects at risk for DFU. The IPM can be included in the screening methods for identification of the foot at risk.

Keywords: diabetes; foot ulcer; indicator plaster method; neuropad; neuropathy disability score; risk; vibration perception.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier estimates of foot ulceration in participants during the study period. Equality of the survivor functions between the groups stratified by different neurological modalities was performed using the log-rank test. (A) abnormal (continuous line) vs. normal (dashed line) indicator plaster method (IPM) (A): X2 = 18.364, p < 0.001; (B) high (≥6) (continuous line) vs. low (<6) (dashed line) neuropathy disability score (NDS): X2 = 20.291, p < 0.001; (C) high (≥25) (continuous line) vs. low (<25) (dashed line) vibration perception threshold (VPT) (Volts): X2 = 14.079, p < 0.001.

Similar articles

Cited by

References

    1. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. . High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. (2007) 50:18–25. 10.1007/s00125-006-0491-1 - DOI - PubMed
    1. Kerr M, Rayman G, Jeffcoate W. Cost of diabetic foot disease to the National Health Service in England. Diabet Med. (2014) 31:1498–504. 10.1111/dme.12545 - DOI - PubMed
    1. Tzeravini E, Tentolouris A, Tentolouris N, Jude EB. Advancements in improving health-related quality of life in patients living with diabetic foot ulcers. Expert Rev Endocrinol Metab. (2018) 13:307–16. 10.1080/17446651.2018.1541403 - DOI - PubMed
    1. Bakker K, Apelqvist J, Schaper NC, International Working Group on Diabetic Foot Editorial B Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. (2012) 28(Suppl 1):225–31. 10.1002/dmrr.2253 - DOI - PubMed
    1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. (2005) 366:1719–24. 10.1016/S0140-6736(05)67698-2 - DOI - PubMed

Publication types